151 related articles for article (PubMed ID: 20021720)
1. Non-invasive prenatal diagnosis using cell-free fetal DNA in maternal plasma from PGD pregnancies.
Li Y; Altarescu G; Renbaum P; Eldar-Geva T; Levy-Lahad E; Margalioth EJ; Zhong X; Hahn S; Holzgreve W
Reprod Biomed Online; 2009 Nov; 19(5):714-20. PubMed ID: 20021720
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay.
Li Y; Page-Christiaens GC; Gille JJ; Holzgreve W; Hahn S
Prenat Diagn; 2007 Jan; 27(1):11-7. PubMed ID: 17154237
[TBL] [Abstract][Full Text] [Related]
3. Size fractionation of cell-free DNA in maternal plasma and its application in noninvasive detection of fetal single gene point mutations.
Li Y; Holzgreve W; Hahn S
Methods Mol Biol; 2008; 444():239-51. PubMed ID: 18425486
[TBL] [Abstract][Full Text] [Related]
4. Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation.
Li Y; Wenzel F; Holzgreve W; Hahn S
Electrophoresis; 2006 Oct; 27(19):3889-96. PubMed ID: 16972300
[TBL] [Abstract][Full Text] [Related]
5. Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma.
Ding C
Methods Mol Biol; 2008; 444():253-67. PubMed ID: 18425487
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
Lo YM
Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
[TBL] [Abstract][Full Text] [Related]
7. Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry.
Li Y; Di Naro E; Vitucci A; Grill S; Zhong XY; Holzgreve W; Hahn S
Fetal Diagn Ther; 2009; 25(2):246-9. PubMed ID: 19506384
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionation.
Li Y; Hahn S; Holzgreve W
Ann N Y Acad Sci; 2006 Dec; 1092():285-92. PubMed ID: 17308152
[TBL] [Abstract][Full Text] [Related]
9. Detection of fetal mutations causing hemoglobinopathies by non-invasive prenatal diagnosis from maternal plasma.
D'Souza E; Sawant PM; Nadkarni AH; Gorakshakar A; Ghosh K; Colah RB
J Postgrad Med; 2013; 59(1):15-20. PubMed ID: 23525053
[TBL] [Abstract][Full Text] [Related]
10. Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing.
Wong D; Moturi S; Angkachatchai V; Mueller R; DeSantis G; van den Boom D; Ehrich M
Clin Biochem; 2013 Aug; 46(12):1099-1104. PubMed ID: 23643886
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.
Li Y; Finning K; Daniels G; Hahn S; Zhong X; Holzgreve W
Prenat Diagn; 2008 Mar; 28(3):203-8. PubMed ID: 18241084
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
[TBL] [Abstract][Full Text] [Related]
13. New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma.
Chitty LS; Griffin DR; Meaney C; Barrett A; Khalil A; Pajkrt E; Cole TJ
Ultrasound Obstet Gynecol; 2011 Mar; 37(3):283-9. PubMed ID: 21105021
[TBL] [Abstract][Full Text] [Related]
14. Detection of SNPs in the plasma of pregnant women and in the urine of kidney transplant recipients by mass spectrometry.
Li Y; Hahn D; Wenzel F; Holzgreve W; Hahn S
Ann N Y Acad Sci; 2006 Sep; 1075():144-7. PubMed ID: 17108204
[TBL] [Abstract][Full Text] [Related]
15. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
16. Detection of paternally inherited fetal point mutations for β-thalassemia in maternal plasma using simple fetal DNA enrichment protocol with or without whole genome amplification: an accuracy assessment.
Ramezanzadeh M; Salehi M; Farajzadegan Z; Kamali S; Salehi R
J Matern Fetal Neonatal Med; 2016; 29(16):2645-9. PubMed ID: 26553322
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood.
Sekizawa A; Purwosunu Y; Matsuoka R; Koide K; Okazaki S; Farina A; Saito H; Okai T
J Obstet Gynaecol Res; 2007 Dec; 33(6):747-64. PubMed ID: 18001438
[TBL] [Abstract][Full Text] [Related]
18. PCR/LDR/capillary electrophoresis for detection of single-nucleotide differences between fetal and maternal DNA in maternal plasma.
Yi P; Chen Z; Zhao Y; Guo J; Fu H; Zhou Y; Yu L; Li L
Prenat Diagn; 2009 Mar; 29(3):217-22. PubMed ID: 19177453
[TBL] [Abstract][Full Text] [Related]
19. Application of fetal DNA in maternal plasma for noninvasive prenatal diagnosis.
Chiu RW; Lo YM
Expert Rev Mol Diagn; 2002 Jan; 2(1):32-40. PubMed ID: 11963800
[TBL] [Abstract][Full Text] [Related]
20. [Cell-free fetal DNA detection in maternal plasma using real-time PCR and cycling probe technology for prenatal screening beta-thalassaemia major].
Chen X; Ren JH; Guo H; Lin LH; Yao QX
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1210-3. PubMed ID: 18676265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
